News

Executive search firm Toft Group places Carmine Stengone as CEO of Pipeline Therapeutics, San Diego, CA

Toft Group Executive Search has placed Mr. Carmine Stengone as Chief Executive Officer with Pipeline Therapeutics in San Diego, California. Mr. Stengone recently served as President and CEO of Avelas Biosciences. Prior to that he was Senior Vice President, Business Development for COI Pharmaceuticals. Mr. Stengone was also Vice President of Corporate Development for Afraxis Holdings, Senior Director of BD with Phenomix Corporation, and has held positions with Anadys Pharmaceuticals and Johnson & Johnson Pharmaceutical Research and Development.

Mr. Stengone holds an MBA from the Johnson Graduate School of Management at Cornell University, an M.S. in Organic Chemistry from Duke University, and a B.S. in Chemistry from Wake Forest University.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles. Toft Group has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Pipeline Therapeutics

Pipeline Therapeutics is using innovative research strategies to develop novel drugs for the treatment of MS and other demyelinated diseases by enhancing the functional restoration of the affected nerves.

Executive search firm Toft Group places Daniela Do Anjos Hanova as Vice President, Human Resources with Exact Sciences in Madison, WI

Toft Group Executive Search has placed Ms. Daniela Dos Anjos Hanova as Vice President of Human Resources for Exact Sciences in Madison, Wisconsin. Ms. Hanova was most recently with AstraZeneca as Global HR Director. Previous to AstraZeneca, Ms. Hanova worked for Abbott as Division HR Director. Earlier in her industry career, she served with Solvay Pharmaceuticals (now Abbott) as Zone HR Director and PriceWaterhouseCooper as Human Resources Services Manager.

Ms. Hanova holds a MA in English and Russian Languages and Literature from Comenius University, Slovakia.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Exact Sciences

Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer.

Executive search firm Toft Group places Nico Pannacciulli, MD, PhD, as Executive Medical Director, Clinical Development with Intercept Pharmaceuticals in San Diego, CA

Toft Group Executive Search has placed Nico Pannacciulli, MD, PhD, as Executive Medical Director, Clinical Development with Intercept Pharmaceuticals in San Diego, California.  Dr. Pannacciulli previously worked with Amgen as Clinical Research Medical Director, Bone Therapeutic Area and was later promoted to Global Development Leader. Before working with Amgen, Dr. Pannacciulli was the Director, Cardiovascular Clinical Research at Gilead Sciences. He also worked with Bristol-Myers Squibb as their Medical Director, CV/Metabolic. Earlier in his industry career, Dr. Pannacciulli was the Associate Director, Clinical Development at Amylin.

Dr. Pannacciulli received his MD from the University of Bari, Italy and his PhD in Endocrine and Metabolic Sciences from the University of Naples, Italy.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Intercept Pharmaceuticals

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada.